Beth C. Seidenberg, Director at Vera Therapeutics, Inc. (VERA), bought 3,466 shares at $7.24 ($25K) on 2023-03-24, disclosed to the SEC on 2023-03-28.
Open-market purchase of $25k VERA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.24 | 1,833 | $13K | 52.9% |
| 2 | $7.24 | 1,633 | $12K | 47.1% |
| Total | $7.24 avg | 3,466 | $25K | 100% |
| Filing → |
| VERA | SELL | 2024-09-20 | $1.3M | — | Filing → |
| SGMT | BUY | 2023-07-20 | $750K | — | Filing → |
| SLRN | BUY | 2023-05-11 | $23.6M | — | Filing → |